Leidos Awarded Contract by National Institutes of Health

Adjuvants are agents that help boost the body's immune response. The single-award, cost-plus-fixed-fee contract has a one-year period of performance valued at Leidos has assembled a high-quality team to further develop and optimize a lead vaccine adjuvant to enhance the efficacy of recombinant anthrax and WNV vaccines.

http://www.sys-con.com/node/2860801